ALTER — Theradiag SA Cashflow Statement
0.000.00%
Last trade - 00:00- €16.44m
- €12.36m
- €12.20m
- 78
- 38
- 18
- 38
Annual cashflow statement for Theradiag SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | — | — | — | — |
| Source: | ARS | ||||
| Standards: | FAS | — | — | — | — |
| Status: | Final | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | -0.787 | — | — | — | — |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.76 | — | — | — | — |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.608 | — | — | — | — |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.39 | — | — | — | — |
| Capital Expenditures | -0.154 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.002 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.156 | — | — | — | — |
| Financing Cash Flow Items | -0.073 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.181 | — | — | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.73 | — | — | — | — |